Showing results (191-200 of 250) with videos related to
Sort By:
Pageof 25
Diagnostics (Basel, Switzerland)|October 27, 2020
Galectin-3 Plasma Levels Are Associated with Risk Profiles in Pulmonary Arterial HypertensionLaura Scelsi, Stefano Ghio, Benedetta Matrone, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 7, 2010
Medical therapy of pericardial diseases: part II: Noninfectious pericarditis, pericardial effusion and constrictive pericarditisMassimo Imazio, Antonio Brucato, Bongani M Mayosi, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 6, 2009
Aetiological diagnosis in acute and recurrent pericarditis: when and howMassimo Imazio, Antonio Brucato, Francesco Giuseppe Derosa, et al.Drug Design, Development and Therapy|June 6, 2017
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q<sub>10</sub> on lipid levels: a randomized, double-blind, placebo controlled studySergio D'Addato, Luciana Scandiani, Giuliana Mombelli, et al.Diabetes Technology & Therapeutics|April 20, 2012
Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patientsGiuseppe Derosa, Pietro D Ragonesi, Anna Carbone, et al.Canadian Journal of Physiology and Pharmacology|August 30, 2013
Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapyGiuseppe Derosa, Arrigo F G Cicero, Ivano G Franzetti, et al.Metabolism: Clinical and Experimental|April 28, 2009
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's studyGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.Current Medical Research and Opinion|February 24, 2009
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trialGiuseppe Derosa, Sibilla A T Salvadeo, Angela D'Angelo, et al.Pharmacotherapy|May 19, 2005
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndromeGiuseppe Derosa, Antonio V Gaddi, Mario N Piccinni, et al.Diabetes Research and Clinical Practice|June 12, 2012
Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patientsGiuseppe Derosa, Anna Carbone, Ivano Franzetti, et al.Pageof 25